Hope for tots: testing seizure drug in infants with rare, severe epilepsy
NCT ID NCT06118255
Summary
This study is testing the safety and effects of a medication called fenfluramine in very young children (1 to under 2 years old) who have Dravet syndrome, a severe form of epilepsy. The main goal is to see if the drug is safe for their hearts and bodies, while also checking if it helps reduce the number of seizures they experience. It involves about 25 infants who will take the drug for up to a year while doctors closely monitor them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRAVET SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ep0213 103
Seattle, Washington, 98105, United States
-
Ep0213 105
Memphis, Tennessee, 38103-2800, United States
-
Ep0213 107
Dallas, Texas, 75207, United States
-
Ep0213 201
Roma, Italy
-
Ep0213 202
Florence, Italy
-
Ep0213 203
Genova, Italy
-
Ep0213 204
Roma, Italy
-
Ep0213 303
Bielefeld, Germany
-
Ep0213 401
London, United Kingdom
-
Ep0213 403
Glasgow, United Kingdom
-
Ep0213 501
Edegem, Belgium
-
Ep0213 502
Brussels, Belgium
Conditions
Explore the condition pages connected to this study.